Heinrich Heine Univ Dusseldorf Dept Neurol Moorenstr 5 D-40225 Dusseldorf GermanyMultiple sclerosis: clinical and laboratory researchKremer D, Kury P, Hartung HP (2018) ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosis. Mult Scler 24:696-700....
Merck KGaA, Darmstadt, Germany today announced it will present data on its approved and investigational multiple sclerosis (MS) treatments at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting.
3, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced it will present data on its approved and investigational multiple sclerosis (MS) treatments at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting. Merck will...
Information about several papers discussed at a conference held October 19-22, 2011 sponsored by the European and Americas Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS and ACTRIMS) on the available drugs used to treat multiple sclerosis is presented. Topics include the safety ...
(S1PR1) and 5 (S1PR5) receptor modulator, versus a first-line treatment, Avonex® (interferon beta-1a) (IFN), in patients with relapsing multiple sclerosis (RMS). The results were presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting, which was held in Paris, October 25-28...
ECTRIMS-ACTRIMS为中枢神经系统脱髓鞘领域全球最大规模的学术盛会,来自109个国家的近万名临床医生、科学家和其他医学专业人员将汇聚于此,共有95场座谈会、422场口头报告和1400余张壁报,为中枢神经系统领域脱髓鞘疾病的最新研究结果和最先进诊疗方案提供讨论平台。
1. Gaertner J, Hauser S, Bar-Or A, et al. Benefit-risk of ofatumumab in treatment-naïve early relapsing multiple sclerosis patients. 8th Joint ACTRIMS-ECTRIMS meeting, MSVirtual2020, September 11–13, 2020. 2. Giovannoni G, Kappos L, Fox RJ, et al. Sustained reduction of disability an...
第8 届 ECTRIMS-ACTRIMS 大会为我们多角度呈现了多发性硬化(MS)的最新研究成果,在提出「MS 前驱期」的概念,提倡早诊早治,减少残障的同时,深入探讨了治疗策略的选择方法,虽然对于早期强化治疗和进阶治疗的意见尚不统一,但已有多项大型研究正在进行中,有望进一步揭晓 MS 治疗策略的优化方向,更好助力个体化治疗。
J. A. De Groot, W. Kamphorst, J. H. Van Waesberghe, P. Van der Valk, F. Barkhof.multiple sclerosis
Moreover, rats with motor cortex lesions neutralizing antibody also prompted plasticity and compensatory growth connected with enhanced functional recovery.EBSCO_AspMultiple Sclerosis